Radiation induced liver injury (RILI) evaluation using longitudinal computed tomography (CT) in image-guided precisionmurine radiotherapy

Abstract

Purpose: We aim to perform image-guided, dose-escalated, well-controlled liverirradiated animal studies and subsequently evaluate radiation induced liver injury (RILI) using longitudinal CT.

Methods: Eighteen 6–8 weeks mice were divided into three groups: control, 15Gy and 30Gy irradiated groups. The animal protocol was approved by the animal care ethics committee of our institution. Precision radiotherapy started with CT simulation, followed by treatment planning using volumetric modulated arc therapy (VMAT), image guidance with cone beam CT (CBCT) and radiation delivery on a medical linear accelerator. Weekly CT was conducted on the same CT simulator using same scanning parameters. At the end of fifth week, all mice were sacrificed, and histological staining was performed. Body weight, liver volume, HUvalues and histogramdistributions were analyzed.

Results: Body weight of irradiation groups was significantly reduced compared to that of the control group (p<0.05). Liver volume in irradiated groups was reduced too. The average liver HU was significantly reduced in irradiated groups (HU mean = 62±3, 48±6, and 36±8 for the control, 15Gy and 30Gy respectively; p _{control vs. 15Gy} < 0.05, p control vs. 30Gy < 0.05). A linear relationship between liver HU and radiation dose was found. Furthermore, HU histogram changes with time and dose showed not only density but also structure might be affected by radiation. HE and Masson Trichrome staining confirmed histological change and increased collagen deposition in irradiated liver.

Conclusion: Longitudinal unenhanced CT is a useful imaging tool to evaluate the severity and progression of radiation induced liver injury.

Keywords

longitudinal computed tomography / radiation induced liver disease / radiation induced liver injury

References

[1] Munoz-SchuffeneggerP, Ng S, DawsonLA. Radiation-Induced Liver Toxicity. Semin Radiat Oncol. 2017;27(4):350-357.

[2] AtunR, Jaffray DA, BartonMB, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16(10):1153-1186.

[3] KoayEJ, OwenD, DasP. Radiation-Induced Liver Disease and Modern Radiotherapy. Semin Radiat Oncol. 2018;28(4):321-331.

[4] GuhaC, Kavanagh BD. Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol 2011;21:256–263.

[5] LewisS, DawsonL, BarryA, Stanescu T, MohamadI, HosniA. Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity. JHEP Rep. 2022;4(8):100498.

[6] De La Pinta AlonsoC. Radiation-induced liver disease in the era of SBRT: a review. Expert Rev Gastroenterol Hepatol. 2020;14(12):1195-1201.

[7] SolimanH, Ringash J, JiangH, et al. Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases. J Clin Oncol. 2013;31(31):3980-3986.

[8] ZhuW, ZhangX, YuM, LinB, YuC. Radiation-induced liver injury and hepatocyte senescence. Cell Death Discov. 2021;7(1):244.

[9] KimJ, JungY. Radiation-induced liver disease: current understanding and future perspectives. Exp Mol Med. 2017;49(7):e359.

[10] WangS, HyunJ, YounB, Jung Y. Hedgehog signaling regulates the repair response in mouse liver damaged by irradiation. Radiat Res. 2013;179:69–75.

[11] ImaedaM, Ishikawa H, YoshidaY, et al. Long-term pathological and immunohistochemical features in the liver after intraoperative wholeliver irradiation in rats. JRadiat Res. 2014;55(4):665-673.

[12] MelinN, Yarahmadov T, Sanchez-TaltavullD, et al. A newmousemodel of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus. JHEP Rep. 2022;4(7):100508.

[13] YannamGR, HanB, SetoyamaK, et al. A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury. Int J Radiat Oncol Biol Phys. 2014;88(2):404-411.

[14] JerajR, CaoY, TenHakenRK, Hahn C, MarksL. Imaging for assessment of radiation-induced normal tissue effects. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S140-S144.

[15] LimkinEJ, SunR, DercleL, et al. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology. Ann Oncol. 2017;28(6):1191-1206.

[16] AertsHJ, Velazquez ER, LeijenaarRT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.

[17] SunR, LimkinEJ, VakalopoulouM, et al. Aradiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PDL1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018;19:1180–1191.

[18] FridmanWH, Zitvogel L, Sautes-FridmanC, KroemerG. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14:717–734.

[19] BramanNM, Etesami M, PrasannaP, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19(1):57.

[20] EmamiB, LymanJ, BrownA, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122.

[21] PanCC, Kavanagh BD, DawsonLA, et al. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S94-S100.

[22] WagnerF, HakamiYA, WarnockG, Fischer G, HuellnerMW, Veit-HaibachP. Comparison of Contrast-Enhanced CT and [18F] FDG PET/CT Analysis Using Kurtosis and Skewness in Patients with Primary Colorectal Cancer. Mol Imaging Biol. 2017;19(5):795-803.

[23] MiftenM, Vinogradskiy Y, MoiseenkoV, et al. Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys. 2021;110(1):196-205.

[24] LawrenceTS, Robertson JM, AnscherMS, JirtleRL, Ensminger WD, FajardoLF. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31(5):1237-1248.

[25] ChiouSY, LeeRC, ChiKH, Chia-Hsien ChengJ, ChiangJH, ChangCY. The triple-phase CT image appearance of post-irradiated livers. Acta Radiol. 2001;42(5):526-531.

[26] HerfarthKK, HofH, BahnerML, et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol aBiol Phys. 2003;57:444-451.

[27] KimuraT, Takahashi S, TakahashiI, et al. The time course of dynamic computed tomographic appearance of radiation injury to the cirrhotic liver following stereotactic body radiation therapy for hepatocellular carcinoma. PLoS One. 2015;10(6):e0125231.

[28] WuZF, ZhangJY, ShenXY, et al. A mouse radiation-induced liver disease model for stereotactic body radiation therapy validated in patients with hepatocellular carcinoma. Med Phys. 2016;43(7):4349.

[29] CaoY, PlattJF, FrancisIR, et al. The prediction of radiation-induced liver dysfunction using a local dose and regional venous perfusion model. Med Phys. 2007;34(2):604-612.

[30] PriceRG, Apisarnthanarax S, SchaubSK, et al. Regional Radiation Dose-Response Modeling of Functional Liver in Hepatocellular Carcinoma Patients With Longitudinal Sulfur Colloid SPECT/CT: A Proof of Concept. Int J Radiat Oncol Biol Phys. 2018;102(4):1349-1356.

[31] ThakurP, OlsonJD, DuganGO, Bourland JD, KockND, ClineJM. Quantitative Assessment and Comparative Analysis of Longitudinal Lung CT Scans of Chest-Irradiated Nonhuman Primates. Radiat Res. 2023;199(1):39-47.

RIGHTS & PERMISSIONS

2024 The Author(s). Precision Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Shandong Cancer Hospital & Institute.

AI Summary ^{中 Eng} ×

Note: Please be aware that the following content is generated by artificial intelligence. This website is not responsible for any consequences arising from the use of this content.

AI Summary AI Mindmap

×

Share on WeChat

Part of a collection:

147

Accesses

0

Citation

Altmetric

Detail

Sections

Recommended

[32] MorinCE, KolbeAB, AlazrakiA, et al. Cancer Therapy-related Hepatic Injury in Children: Imaging Review from the Pediatric LI-RADS Working Group. Radiographics. 2023;43(9):e230007.